ASK REDCHAT ANYTHING ABOUT AN2 THERAPEUTICS, INC.
AN2 Therapeutics, Inc. (NASDAQ: ANTX)
Listen to this Section
$4.95
-0.1900
(
-3.70% )
176.2K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Market Data
|
| Open |
$4.95 |
| Previous Close |
$5.14 |
| Volume |
176.2K |
| Market Cap |
$187.28M |
| Day Range |
$4.71 - $5.42 |
| 52 Week Range |
$1.00 - $6.91 |
| Shares Outstanding |
36.02M |
| Change % |
-3.70% |
| Net Change |
▼ -0.1900 |
| Insider Ownership |
-0.18% |
| Exchange |
NASDAQ |
| Sector | Miscellaneous |
| Industry | None |
| IPO Year | 2022 |
| Country | United States |
| Underwriter | TD Cowen, Leerink Partners, Evercore ISI, Oppenheimer & Co., more |
Insider Ownership Transactions
Total Amount Purchased:
-1,219,102.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-03-18 |
Sale |
-30000.00 |
Krause Kevin Michael |
| 2024-03-18 |
Sale |
-27500.00 |
Chanda Sanjay |
| 2024-03-18 |
Sale |
-30000.00 |
Eckburg Paul |
| 2024-03-18 |
Sale |
-30000.00 |
Eizen Joshua M |
| 2024-03-18 |
Sale |
-27500.00 |
Day Lucy |
| 2024-01-19 |
Sale |
-100000.00 |
Zakrzewski Joseph S |
| 2024-01-18 |
Sale |
-84093.00 |
Adjuvant Global Health Technology Fund, L.P. |
| 2024-01-18 |
Sale |
-84093.00 |
Aziz Kabeer |
| 2024-01-17 |
Sale |
-706.00 |
Readnour Robin Shane |
| 2024-01-12 |
Sale |
-1869.00 |
Readnour Robin Shane |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
60 |
Nov 12, 2025 |
| 8-k |
8K-related |
11 |
Nov 12, 2025 |
| 4 |
Insider transactions |
1 |
Nov 06, 2025 |
| 4 |
Insider transactions |
1 |
Nov 06, 2025 |
| 4 |
Insider transactions |
1 |
Oct 14, 2025 |
| 4 |
Insider transactions |
1 |
Oct 14, 2025 |
| 4 |
Insider transactions |
1 |
Oct 14, 2025 |
| 8-k |
8K-related |
11 |
Aug 12, 2025 |
| 10-q |
Quarterly Reports |
61 |
Aug 12, 2025 |
| 4 |
Insider transactions |
1 |
Jul 11, 2025 |